2025 Pharmaceutical Companies Vaccines 
European Pharmaceutical Review
OCTOBER 6, 2023
Positive interim results from Moderna’s Phase I/II trial of mRNA-1083 , an investigational vaccine designed to immunise against both influenza and COVID-19, have been released. There are several benefits of the combination vaccine as a preventative measure against these respiratory conditions, according to the pharmaceutical company.
pharmaphorum
OCTOBER 18, 2021
The development of COVID-19 vaccines required levels of cooperation and pioneering science comparable to the Apollo space programme. Within 12 months of the outbreak, vaccines were being deployed to prevent severe infections, hospitalisation, and death. billion people have been fully vaccinated. And there are many.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
APRIL 25, 2023
As the prophylactic landscape for malaria has changed in recent years with vaccine approvals, major issues still remain with ensuring access in remote communities. However, making sure the vaccine reaches everyone can be challenging due to the storage requirements. The Mosquirix vaccine contains two vials.
pharmaphorum
MARCH 12, 2021
If the power of the life sciences industry to innovate and collaborate were ever in doubt, the speed at which vaccines for COVID-19 were discovered, developed, trialled, approved and manufactured have confirmed just how dynamic the industry can be. And those volumes will only increase.
The Checkup by Singlecare
SEPTEMBER 10, 2024
There have been several biosimilars approved, including Wezlana , Selarsdi, and Pyzchiva, but they are not expected to be available until early 2025. It is made by the pharmaceutical company Amgen, Inc. But Stelara is a biologic product , meaning it will have what’s called a biosimilar instead of a generic version.
pharmaphorum
JULY 1, 2021
More recently, the rapid development of Moderna’s COVID-19 vaccine, which used many of the principles of synthetic biology, is yet more proof that this is an area on the cusp of the pharmaceutical R&D mainstream. About the interviewee.
pharmaphorum
OCTOBER 12, 2022
Del Bourgo highlights that genomic treatments work in a similar way to mRNA, which has been used in COVID-19 vaccines. As technology has evolved, biotech and pharmaceutical companies have increasingly leaned on AI to support drug development – including to make sense of the vast amounts of healthcare data available to them.
Expert insights. Personalized for you.
105 
Let's personalize your content